EQ Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-600
Closed -$32.4K 68
2025
Q4
$32.4K Buy
+600
New +$28.9K 0.02% 110
2025
Q3
Sell
-600
Closed -$27.8K 69
2025
Q2
$27.8K Hold
600
0.02% 104
2025
Q1
$36.6K Buy
+600
New +$35K 0.03% 98

Other funds holding BMY

EQ Wealth Advisors's BMY Position: Q1 2026 in Review

EQ Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 600 shares — an estimated $32.4K sold.

EQ Wealth Advisors first reported a position in BMY in Q1 2025 and held it in 3 quarters. The position peaked at $36.6K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • EQ Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • EQ Wealth Advisors sold 600 Bristol-Myers Squibb shares in Q1 2026, an estimated $32.4K.
  • EQ Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2025 and held it in 3 quarters.
  • EQ Wealth Advisors's Bristol-Myers Squibb position peaked at $36.6K in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on EQ Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.